Physical Activity for PLWH and Unhealthy Drinking
Launched by BOSTON UNIVERSITY · Aug 16, 2022
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how physical activity can help people living with HIV (PLWH) who also struggle with unhealthy drinking habits. Unhealthy drinking can make health problems worse for those with HIV, so the researchers want to see if a home-based program that encourages physical activity can improve their overall health and reduce alcohol use. Participants will be randomly assigned to one of two groups: one group will receive extra support and guidance to increase their physical activity, while the other group will only use a Fitbit to track their daily steps with minimal help.
To join the study, participants must confirm they have HIV and report unhealthy drinking habits, such as exceeding a certain number of drinks per week. They should also have a smartphone and be less active than the recommended amount of exercise. The trial will last 12 weeks, and participants will have follow-up assessments three and six months later to see how they are doing. This study is currently recruiting participants, and it aims to provide valuable insights into how physical activity can positively affect the health of people living with HIV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have the ability to confirm HIV diagnosis either through visual evidence of ART medication or medical record
- • Engaged in unhealthy drinking, defined as: \>7 drinks for women / \> 14 drinks for men per week OR ≥ 3 drinks for women / ≥4 drinks for men on one occasion in the past month.
- • Have a smartphone
- • Considered low active: 150 minutes or less of average weekly physical activity
- • Lives in the USA
- • Has a U.S. mailing address
- Exclusion Criteria:
- • History of bipolar, schizophrenia, schizoaffective disorder or mania per self report.
- • History of withdrawal-related seizures or delirium tremens per self report.
- • Current non-pharmacological treatment for alcohol use disorder.
- • Unable to provide one or more individuals for follow up contact.
- • Current DSM-5 diagnosis of anorexia or bulimia nervosa per self report.
- • Marked organic impairment according to responses to the diagnostic assessments
- • Physical or medical problems that would not allow safe participation in a program of moderate intensity PA
- • Individual who is unwilling to provide their sex at birth
- • Limited or non-readers
About Boston University
Boston University, a leading research institution located in Boston, Massachusetts, is dedicated to advancing health sciences through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing health challenges. Boston University is committed to ethical research practices, patient safety, and the dissemination of findings to foster greater understanding and advancements in medical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Michael D Stein, MD
Principal Investigator
Boston University, School of Public Health - Health Law Policy & Management
Lisa Quintiliani, PhD
Principal Investigator
Tufts Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials